JB Chemicals and Pharmaceuticals Ltd recalls Cetirizine Hydrochloride…
JB Chemicals and Pharmaceuticals Ltd recalls Cetirizine Hydrochloride Tablets USP 10 mg
- Published
- 29 Oct 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Tablet/Capsules Imprinted with Wrong ID
Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10.
Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50
- Brand / company
- JB Chemicals and Pharmaceuticals Ltd
- Codes / lots
- Lot # PY925014A; Exp. 1/31/2028 | Lot # PY925014, PY925013, Exp. 1/31/2028
- Distribution
- U.S. Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 29 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.